Nexus NeuroTech Ventures
Overview
Nexus NeuroTech Ventures is dedicated to advancing pioneering technologies — including medical devices, software, diagnostics, technology-enabled care services and research tools — for brain disorders. Spanning seed through crossover, Nexus invests with the goal of improving the lives of people affected by neurodevelopmental, neurodegenerative and neuropsychiatric conditions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beacon Biosignals | Apr 2026 | Series B Extension | Co-investor |
| NeuraWorx Medical Technologies | Dec 2025 | Seed | Lead |
| Lotus Neuro | Dec 2025 | Corporate Funding | Lead |
| Modulight Biotherapeutics | Nov 2025 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Jordi Parramon
CEO, General Partner and Co-founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Nexus NeuroTech Ventures based?
Nexus NeuroTech Ventures is headquartered in San Francisco, California, United States.
When was Nexus NeuroTech Ventures founded?
Nexus NeuroTech Ventures was founded in 2023.
How many portfolio companies does Nexus NeuroTech Ventures have?
Nexus NeuroTech Ventures has 16 portfolio companies in Caplight's dataset.
What are some companies in Nexus NeuroTech Ventures's portfolio?
Recent investments visible on Caplight include Beacon Biosignals, NeuraWorx Medical Technologies, Lotus Neuro, Beacon Biosignals, Modulight Biotherapeutics.
What was Nexus NeuroTech Ventures's most recent investment?
Nexus NeuroTech Ventures's most recent investment on Caplight was in Beacon Biosignals in 2026.
What sectors does Nexus NeuroTech Ventures focus on?
Nexus NeuroTech Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Consumer & Commerce, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Nexus NeuroTech Ventures focus on?
Nexus NeuroTech Ventures typically invests at the MultiStage stage.
What is Nexus NeuroTech Ventures's AUM?
Nexus NeuroTech Ventures's assets under management are estimated between $100.0M and $250.0M.